<DOC>
	<DOCNO>NCT00336284</DOCNO>
	<brief_summary>This study multi-center , prospective randomize trial . The primary objective study demonstrate use BIOTRONIK Home Monitoring system ( HM ) safely reduce number regularly schedule office follow-up visit , compare conventional method implantable cardioverter defibrillator ( ICD ) follow-up .</brief_summary>
	<brief_title>TRUST : Lumos-T Safely RedUceS RouTine Office Device Follow-up</brief_title>
	<detailed_description />
	<criteria>Implanted within last 45 day consider implant BIOTRONIK ICD Home Monitoring ( HM ) /Intracardiac Electrogram ( IEGM ) Online technology , legally market future generation device HM/IEGM Online . Able utilize HM system throughout study Ability give inform consent Geographically stable able return regular followup fifteen ( 15 ) month At least 18 year old Patients fulfill inclusion criterion Pacemaker dependent Currently enrol cardiac clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Telemonitoring</keyword>
	<keyword>ICD</keyword>
	<keyword>Reduction office follow-up</keyword>
</DOC>